Chester County News and Community Website
LANGHORNE, PA — NEXGEL Inc. (NASDAQ: NXGL) will present to investors at the Planet MicroCap Conference in Las Vegas later this month as the hydrogel products manufacturer seeks to increase …
NEXGEL Expands Investor Outreach With MicroCap Conference Appearance Read More LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) released clinical study data showing its hydrogel patch reduced airborne particulate exposure during laser hair removal procedures, as healthcare providers and regulators increase …
NEXGEL Study Targets Safety Risks in Laser Hair Removal Read More LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) appointed orthopedic and biologics sales executive Dave Hazard as vice president of sales for its BIONX Surgical division as the company seeks to …
NEXGEL Hires Medtech Executive to Expand Surgical Unit Read More LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) appointed Sequence LifeScience executives Brian Kieser and Kevin Harris to its board following a recent financing tied to NEXGEL’s acquisition of a degenerative …
NEXGEL Adds Sequence Executives to Board After Deal Financing Read More LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) recently appointed Ian Blackman as chief financial officer as the company works to complete a planned acquisition of regenerative biomaterial assets from Celularity …
NEXGEL Appoints Ian Blackman CFO Amid Celularity Deal Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) recently closed its previously announced license and acquisition of a portfolio of regenerative biomaterial products from Celularity Inc. (NASDAQ: CELU) and launched a …
NEXGEL Closes Celularity Asset Deal, Launches BioNX Surgical Read More LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) has rescheduled its shareholder update conference call to April 23, 2026, at 4:30 p.m. ET, as it revises financing plans tied to a …
NEXGEL Reschedules Shareholder Call, Revises Celularity Financing Read More LANGHORNE, PA — NEXGEL Inc. (Nasdaq: NXGL) has rescheduled its shareholder update conference call to April 15, 2026, at 4:30 p.m. Eastern time as it revises financing plans tied to …
NEXGEL Reschedules Shareholder Call, Revises Financing Plan Read More LANGHORNE, PA — NEXGEL Inc. (Nasdaq: NXGL) said it will pay $15 million upfront to license and acquire a portfolio of regenerative biomaterial products from Celularity Inc. (Nasdaq: CELU), with …
NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio Read More LANGHORNE, PA — NEXGEL Inc. (NASDAQ: NXGL) announced it has signed a definitive agreement to license and acquire a portfolio of regenerative biomaterial products from Celularity Inc. (NASDAQ: CELU), a …
NEXGEL Signs Agreement to Acquire Regenerative Biomaterial Portfolio Read More